Breaking News

PCI Invests $20M in Biotech & Advanced Injectable Delivery Forms

Demand for biotech packaging drives significant PCI investment at multiple locations worldwide

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PCI Pharma Services (PCI) has unveiled plans to invest more than $20 million to support biologic medicines and advanced injectable delivery forms. PCI will begin by expanding its biotech clinical and commercial packaging and release testing capability at its Center of Excellence in Philadelphia. Part of the investment will also be used to expand cold chain capacity at numerous global locations to further support its existing biotech infrastructure.   The latest investment will include capacity...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters